Results 181 to 190 of about 50,960 (274)

Modeling Predicts Direct-Acting Antiviral Therapy for 5-Weeks May Cure Recent or Chronic Hepatitis C Infection Among People With Undetectable Viral RNA by Day 7. [PDF]

J Infect Dis
Goyal A, Cotler SJ, Matthews GV, Page K, Kushner T, Etzion O, Martinello M, Dahari H.   +7 more
europepmc   +1 more source

Timing of Earliest Documented Positive Hepatitis C Laboratory Result Relative to Delivery Among Pregnant Persons With Active Infection in West Virginia, 2022–2023

Journal of Viral Hepatitis, Volume 33, Issue 11, November 2026.
ABSTRACT Direct‐acting antiviral therapy can cure hepatitis C virus (HCV) infection; however, because treatment is not recommended during pregnancy, preconception treatment remains the primary strategy to prevent perinatal HCV exposure. West Virginia birth records from 2022 to 2023 were linked with statewide HCV laboratory surveillance data.
Kady Pack, Mamoon Yousaf, Rachel A. Wattick, Brett Armstrong, Birgit Shanholtzer, Tonya Chaney, Shannon McBee, Alana G. Hudson   +7 more
wiley   +1 more source

Rare and Novel Hepatitis C Virus Genotype Subtypes and Response to Sofosbuvir/Velpatasvir in A5360 (MINMON) Clinical Trial

Journal of Viral Hepatitis, Volume 33, Issue 11, November 2026.
ABSTRACT The introduction of potent, well‐tolerated direct‐acting antivirals (DAAs) has transformed hepatitis C virus (HCV) therapy and spurred global elimination efforts. However, the extensive genetic diversity of HCV may affect antiviral efficacy, particularly in low and middle‐income regions where limited data currently exist.
Win Min Han, Sunil Solomon, Sandra Wagner‐Cardoso, Jiani Li, Aiyappa Parvangada, Mark Sulkowski, Susanna Naggie, Ross Martin, Hongmei Mo, Evguenia Maiorova, David Wyles, the ACTG A5360 study team   +11 more
wiley   +1 more source

Prevalence of Hepatitis C Infection and Treatment Initiation Following Dried Blood Spot Testing in New South Wales, Australia

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background and Aims To achieve hepatitis C (HCV) elimination by 2030, testing and treatment must reach people most at risk. Dried blood spot (DBS) testing offers an alternative to venepuncture, suitable for community and prison settings. This study evaluated HCV infection prevalence and treatment initiation among people receiving DBS testing ...
Annabelle Stevens, Anna Conway, Nigel Carrington, Evan B. Cunningham, Alison D. Marshall, Janaki Amin, Phillip Read, Tracey Brown, Rick Varma, Bianca Prain, Philip Cunningham, Gregory J. Dore, Jason Grebely   +12 more
wiley   +1 more source

Universal Opt-Out Hepatitis C Virus Testing and Treatment on Entry in California State Prisons.

JAMA Intern Med
Ye Z, Lucas KD, Furukawa NW, Honeycutt AA, Kalauokalani D, Krawiec AT, Puente T, Salomon JA, Reitsma MB.   +8 more
europepmc   +1 more source

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of Georgia. [PDF]

PLOS Glob Public Health
Walker JG, Tskhomelidze Schumacher I, Shadaker S, Gabunia T, Tohme RA, Abutidze A, Getia V, Vickerman P.   +7 more
europepmc   +1 more source

Updated DaaS platform

D2.3 Updated DaaS platform (O; M18; Lead: SOTON), including support for newly acquired datasets, usage-optimised following the lessons learned in the first round of the call, tutorials, and documentation.
openaire   +1 more source

Real-world effectiveness of pangenotypic direct-acting antivirals in chronic hepatitis C: A retrospective cohort study. [PDF]

Medicine (Baltimore)
Çirkin Doruk B, Uğuz M.
europepmc   +1 more source

Peer review of the pesticide risk assessment of the active substance capric acid

EFSA Journal, Volume 24, Issue 11, November 2026.
Abstract The conclusions of the European Food Safety Authority (EFSA) following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State, Greece, and co‐rapporteur Member State, Austria, for the pesticide active substance capric acid are reported.
European Food Safety Authority (EFSA), Fernando Álvarez, Maria Arena, Domenica Auteri, Sofia Batista Leite, Marco Binaglia, Anna Federica Castoldi, Teresa Chavez Capilla, Arianna Chiusolo, Angelo Colagiorgi, Mathilde Colas, Federica Crivellente, Chloe De Lentdecker, Isabella De Magistris, Julia Fabrega, Gabriella Fait, Franco Ferilli, German Giner Santonja, Varvara Gouliarmou, Alessio Ippolito, Frederique Istace, Dimitra Kardassi, Aude Kienzler, Anna Lanzoni, Roberto Lava, Renata Leuschner, Alberto Linguadoca, Mariano Lopez Romano, Jochem Louisse, Christopher Lythgo, Iris Mangas, Silvia Mazzega, Andrea Mioč, Ileana Miron, Tunde Molnar, Laura Padovani, Vincenzo Padricello, Martina Panzarea, Juan Manuel Parra Morte, Simone Rizzuto, Miguel Santos, Rositsa Serafimova, Rachel Sharp, Csaba Szentes, Anne Theobald, Manuela Tiramani, Giorgia Vianello, Laura Villamar‐Bouza, Galini Mavriou, Amarela Becirovic   +49 more
wiley   +1 more source

Maturity-dependent changes in the nutritional, functional, mineral, and structural properties of dragon fruit peel (<i>Selenicereus</i> spp.). [PDF]

Front Plant Sci
Balaji M, Das U, Vashishth R.
europepmc   +1 more source